When development teams source Latanoprost, the main concern is rarely the chemical name itself, but how consistently the material performs during formulation and stability testing. This product is supplied for that exact purpose: to support reproducible development of glaucoma therapies where prostaglandin analogues are sensitive to light, temperature and solvent systems.

Instead of positioning this material as a finished solution, it is offered as a controlled, well-documented raw input that allows formulation scientists and QC teams to work with predictable variables from the outset.

Identity and Core Parameters

 

• CAS Number: 130209-82-4
• Molecular Formula: C₂₆H₄₀O₅
• Molecular Weight: ~432.59 g/mol
• Physical State: Pale yellow to clear oil or semi-solid, depending on storage conditions
• Assay / Purity: ≥ 98% by HPLC (lot-specific)
• Chemical Class: Prostaglandin F₂α analogue
• Intended Use: Pharmaceutical development and manufacturing input (non-finished dosage form).

Each batch is released only after analytical confirmation of identity and purity, with results documented in the accompanying Certificate of Analysis.

Why Formulation Teams Choose This Supply

 

 

• Predictable handling behavior

The material shows stable performance when handled under recommended light-protected and low-temperature conditions, reducing trial-and-error during early formulation stages.

 

• Controlled impurity profile

Impurity and degradation trends are monitored per batch, allowing teams to assess compatibility with their own acceptance criteria rather than relying on generic claims.

 

• Suitable for ophthalmic workflows

Commonly evaluated in the development of intraocular pressure-lowering products, where low-dose accuracy and chemical stability are critical.

 

• Consistent batch-to-batch quality

Designed to minimize variability that could otherwise trigger re-validation in formulation or analytical methods.

Storage, Handling And Transport Consideration

 

• Storage:
•  

Short-term storage at 2–8 °C is acceptable; for extended periods, –20 °C is recommended. Light and moisture exposure should be minimized at all stages.

• Handling:
•  

Best handled under subdued light using solvent systems outlined in the technical data sheet. Repeated temperature cycling should be avoided.

• Transport:
•  

Packed in moisture-barrier containers with protective insulation. Cold-chain shipping options are available for warmer transit routes.

These measures help preserve chemical integrity from dispatch through to final use.

Documentation & Regulatory Support

 

Every Shipment Includes Documentation Typically Required During Supplier Qualification:

 

• Certificate of Analysis (COA)
• MSDS / TDS
• Batch traceability information
• Stability or impurity summaries (available upon request)

 

This documentation structure is intended to reduce back-and-forth during audits or internal supplier approval.

Ordering and Supply Model

 

• Evaluation quantities are available for laboratory validation before scale-up
• Once approved, quantities can be increased to support pilot or commercial manufacturing
• Packaging formats and labeling can be adapted to internal warehouse or production needs
• Long-term supply planning can be aligned with forecasted production schedules

 

This flexible approach allows development teams to progress without over-committing at early stages.

Frequently Asked Questions (FAQs)

 

 

Q: Is this material suitable for finished drug use?

 

A: No. It is supplied as a pharmaceutical raw material for formulation, development and manufacturing purposes only.

 

Q: Can we request analytical data beyond the standard COA?

 

A: Yes. Additional impurity or stability data can be provided to support internal validation or regulatory review.

 

Q: How should incoming batches be qualified?

 

A: We recommend confirming identity and assay against your internal reference standards using the supplied COA as a baseline.

 

Q: Is long-term supply possible after validation?

 

A: Yes. Once the material is approved internally, we can support scheduled or project-based supply.